Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Lung cancer is one of the leading causes of cancer-related death. Lung cancer mortality has decreased over the past decade, which is partly attributed to improved treatments. Curative surgery for patients with early-stage lung cancer is the standard of care, but not all surgical treatments have a go...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yurong Peng, Zhuo Li, Yucheng Fu, Yue Pan, Yue Zeng, Junqi Liu, Chaoyue Xiao, Yingzhe Zhang, Yahui Su, Guoqing Li, Fang Wu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2023-01-01
Colección:	Frontiers in Oncology
Materias:	perioperative period perioperative immunotherapy neoadjuvant therapies immunotherapy neoadjuvant immune monotherapy adjuvant therapy biomarkers
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1011810/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!